Home
Saturday, May 18, 2024, 6:30-7:45 pm ET Sunday, May 19, 2024, 6:30-7:30 pm ET Sunday, May 19, 2024, 6:30-8:00 pm
Saturday, May 18, 2024, 6:30-7:45 pm ET Sunday, May 19, 2024, 6:30-7:30 pm ET Sunday, May 19, 2024, 6:30-8:00 pm
Is basal cell carcinoma on the vermilion lip a distinctly rare phenomenon, sparsely documented in existing literature?
Sunday, June 2, 2024 | 6:45 pm – 8:15 pm CT Supported by an independent educational grant from Takeda Pharmaceuticals, Inc. Join us in Chicago…
Supported by an independent educational grant from Servier. Join us for an interactive a nd engaging symposium that takes a deep dive into the latest…
Mark Lebwohl, MD, and Saakshi Khattri, MD, discuss the evolving landscape of plaque psoriasis treatments over the past year.
A 5-expert panel continues their conversation on atopic dermatitis, exploring beyond steroids and addressing unmet needs.
Supported by an independent educational grant from Servier. Join us for an interactive a nd engaging symposium that takes a deep dive into the latest…
This case series describes the clinical features, antifungal susceptibility, and genome sequencing of Trichophyton indotineae in 11 patients in New York City.
Last week, the FDA approved an sBLA for Sandoz’s adalimumab-adaz in various strengths, including 10 mg/0.1 mL, 20 mg/0.2 mL, and 80 mg/0.8 mL.
Muscle spasms are the most common adverse event experienced by patients treated with hedgehog inhibitors for basal cell carcinomas.
J Clin Aesthet Dermatol. 2024;17(5):48–52. by Jonathan Nevin Yu, MD, FPDS; Camille Angeles, MD, FPDS; Hester Bueser, MD, FPDS; and Antonio Sison, MD, FPPA, FPDS…